6-81752010-ACCGCCGAAGTCGCCGCCGCCGAAGTCGCCGCCGCCGAAGTCGCCG-ACCGCCGAAGTCGCCGCCGCCGAAGTCGCCG
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 2P and 16B. PM4BP6_Very_StrongBA1
The NM_017633.3(TENT5A):c.117_131delCGGCGACTTCGGCGG(p.Gly40_Gly44del) variant causes a disruptive inframe deletion change. The variant allele was found at a frequency of 0.2 in 1,340,024 control chromosomes in the GnomAD database, including 44,155 homozygotes. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.23 ( 3795 hom., cov: 0)
Exomes 𝑓: 0.20 ( 40360 hom. )
Consequence
TENT5A
NM_017633.3 disruptive_inframe_deletion
NM_017633.3 disruptive_inframe_deletion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 5.41
Genes affected
TENT5A (HGNC:18345): (terminal nucleotidyltransferase 5A) Enables RNA binding activity. Predicted to be involved in mRNA stabilization. Predicted to act upstream of or within response to bacterium. Implicated in lung non-small cell carcinoma; osteoarthritis; and osteogenesis imperfecta type 18. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -14 ACMG points.
PM4
Nonframeshift variant in NON repetitive region in NM_017633.3.
BP6
Variant 6-81752010-ACCGCCGAAGTCGCCG-A is Benign according to our data. Variant chr6-81752010-ACCGCCGAAGTCGCCG-A is described in ClinVar as [Benign]. Clinvar id is 402846.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-81752010-ACCGCCGAAGTCGCCG-A is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.288 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TENT5A | NM_017633.3 | c.117_131delCGGCGACTTCGGCGG | p.Gly40_Gly44del | disruptive_inframe_deletion | 2/3 | ENST00000320172.11 | NP_060103.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TENT5A | ENST00000320172.11 | c.117_131delCGGCGACTTCGGCGG | p.Gly40_Gly44del | disruptive_inframe_deletion | 2/3 | 1 | NM_017633.3 | ENSP00000318298.6 | ||
TENT5A | ENST00000369756.3 | c.360_374delCGGCGACTTCGGCGG | p.Gly121_Gly125del | disruptive_inframe_deletion | 2/3 | 1 | ENSP00000358771.3 | |||
TENT5A | ENST00000369754.7 | c.174_188delCGGCGACTTCGGCGG | p.Gly59_Gly63del | disruptive_inframe_deletion | 2/3 | 1 | ENSP00000358769.3 |
Frequencies
GnomAD3 genomes AF: 0.231 AC: 32262AN: 139508Hom.: 3797 Cov.: 0
GnomAD3 genomes
AF:
AC:
32262
AN:
139508
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.197 AC: 235921AN: 1200438Hom.: 40360 AF XY: 0.198 AC XY: 119588AN XY: 602938
GnomAD4 exome
AF:
AC:
235921
AN:
1200438
Hom.:
AF XY:
AC XY:
119588
AN XY:
602938
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.231 AC: 32254AN: 139586Hom.: 3795 Cov.: 0 AF XY: 0.234 AC XY: 15839AN XY: 67668
GnomAD4 genome
AF:
AC:
32254
AN:
139586
Hom.:
Cov.:
0
AF XY:
AC XY:
15839
AN XY:
67668
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Aug 12, 2019 | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Mar 29, 2016 | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at